{"id":"W2729141564","doi":"10.1093/annonc/mdx289","title":"Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":272,"is_retracted":false,"has_abstract":false,"ca_institutions":"Jewish General Hospital","funders":"Bayer HealthCare; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Medicine; Internal medicine; Neutropenia; Lymphoma; Gastroenterology; Aggressive lymphoma; Follicular lymphoma; Adverse effect; Rituximab; Phases of clinical research; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000704404,0.001048969,0.001713434,0.0004009695,0.0004004177,0.001029336,0.0007325847,0.0008555774,0.003014673],"category_scores_gemma":[0.0003800794,0.0003991383,0.0007825531,0.0003734861,0.0007089221,0.0005837815,0.0002849588,0.002554753,0.0008314549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001054088,"about_ca_system_score_gemma":0.0014902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001796354,"about_ca_topic_score_gemma":0.005180681,"domain_scores_codex":[0.9998266,0.00006100769,0.000006589125,0.00002966732,0.00001498354,0.00006122096],"domain_scores_gemma":[0.9996654,0.00003291607,0.0000409227,0.00002470468,0.00001615522,0.0002199634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5595606,0.07495718,0.01014877,0.001370691,0.002549363,0.0007553051,0.0004535413,0.007453639,0.08159658,0.001255468,0.01874679,0.2411521],"study_design_scores_gemma":[0.6184025,0.3396178,0.01861689,0.00007223364,0.0008323836,0.0008087975,0.0001396795,0.004225137,0.007179364,0.0008086673,0.009235719,0.00006090246],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875329,0.003856421,0.0007760005,0.000764602,0.0001555726,0.001485545,0.00118647,0.000188294,0.00405417],"genre_scores_gemma":[0.9873441,0.00247334,0.001244102,0.001078326,0.0001112432,0.001442261,0.002228743,0.00004112362,0.004036741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003014673,"threshold_uncertainty_score":0.01008511,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09953814874158444,"score_gpt":0.4373143449775114,"score_spread":0.3377761962359269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}